Get started

Stockpicks

$HEXOHEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.
HLong
by BADQOMOCAWGOWLD
$HCDIHarbor Custom Development, Inc. engages in the real estate development business in Western Washington's Puget Sound region. The company undertakes projects, such as residential lots, home communities, and single family and multi-family properties. It is involved in the land development cycle activities, including land acquisition, entitlements, construction of project infrastructure, home building, marketing, sales, and management of various residential projects. The company was formerly known as Harbor Custom Homes, Inc. and changed its name to Harbor Custom Development, Inc. in August 2019. Harbor Custom Development, Inc. was founded in 2014 and is headquartered in Gig Harbor, Washington.
HLong
by BADQOMOCAWGOWLD
Big pump on Zynerba pharmaceuticals NASDAQ:ZYNE Last week we crossed important level on weekly chart and it's been followed with strong movement. I expect possible pullback to weekly SD and then rise to the next level. I recommend to look on lower TF for entry if yo uare not in the trade already. In the case you entered on the bottom then move SL under weekly SD and let it go to TP1. We can see the same move in other instruments. I am long on: NASDAQ:TLRY NYSE:ACB NYSE:FVRR NASDAQ:BIDU NYSE:DASH NASDAQ:GOOGL NYSE:NIO NASDAQ:GNUS NYSE:PFE If you find this useful then give like to this post and comment. Thanks! Good luck! M This is not any financial advise, always check the market before entering any position.
ZLong
by Muzaaa
Shorting MACY's into the earnings :) I am Shorting MACY's into the earnings via PUTS for mid March. Overall brick and mortar retail has NOT comeback yet and NYC is a ghost town. Macy's is the next JC Penny's, they are not there yet but are due for a pull back. Momentum and Volume have been no where in sight over the last week for this stock and its sitting at a 1 year high.. I am no genius but I would assume that its due for a fall. to $12's maybe even $10's if the market over reacts. I am betting against the trend here so I am taking a less risky approach by shorting via PUT contracts for mid march which will give the earnings a chance to sell off. I am operating under the assumption that because of my above points, that the earnings will be a missed target. I picked up some $16.50 PUT contracts for Mid March.
NYSE:MShort
by TheStockMarketSniper
1
DSS Technical Analysis 🧙Document Security Systems Inc operates in the security and commercial printing, packaging and plastic ID markets. The company develops, markets, manufactures and sells paper and plastic products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It is organized into the operating segments of Packaging and Printing; Plastics; Digital; Technology management; and Corporate. The Packaging and Printing, and Plastics segments, which are the key revenue-generating segments, are engaged in the printing and production of paper, cardboard and plastic documents with a wide range of features designed for the protection of documents against unauthorized duplication and altering. Document Security Systems, Inc. a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the pricing of an upsized underwritten public offering with gross proceeds to the Company expected to be approximately $34.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The public offering equates to 12,319,346 shares of the Company’s common stock at a price of $2.80 per share. The Company intends to use the net proceeds from this offering, together with their existing cash, to fund the development and growth of new business lines, acquisition opportunities, and general corporate and working capital needs. The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of shares of common stock offered in the public offering to cover over-allotments, if any, which would increase the total gross proceeds of the offering to approximately $39.7 million, if exercised in full. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
AMEX:DSSLong
by unfair_advantage
2
Teradata Soars on Strong Earnings and Demand for CloudTeradata Soars on Strong Earnings and Demand for Cloud Shares soared Friday after the data-analytics company reported stronger-than-expected fourth-quarter earnings (triple-digit cloud growth), benefiting from corporate demand for enterprise software and cloud services. Annual recurring revenue (ARR) increased 11% from the prior year period(1) Public cloud ARR increased to $106 million, a 165% increase from the end of 2019(1) Fourth-quarter recurring revenue of $383 million versus $350 million, an increase of 9% reported and 8% in constant currency , and exceeded the Company’s guidance of $371 million to $373 million(1) Fourth-quarter earnings per diluted share (EPS), cash from operations and free cash flow(2) exceeded the Company’s expectations finance.yahoo.com
NYSE:TDC
by AlenCiken
Why ATA Creativity Skyrocketed 951% yesterdayWhy ATA Creativity Skyrocketed 951% yesterday There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media. ATA shares were buoyed — thanks to discussions stock trading groups on Facebook, Discord chat rooms, the r/Daytrading subreddit, Twitter hashtags, and YouTube channels before the market opened. Many of these posts mentioned the advantages of the high volume and relatively low float (31.74M) of the stock. ATA Creativity is not on the list of most talked about stocks on r/WallStreetBets, as compiled by Swaggystocks.
NASDAQ:AACG
by AlenCiken
PAAS Technical Analysis 🧙Pan American Silver Corp is a mining company focused exclusively on the exploration and development of silver mines. It produced roughly 22 million ounces of silver in 2011. The company operates primarily in Central and South America. It also sells the byproducts from its silver mining operations, including zinc, lead, copper, and gold. Pan American Silver is based in British Columbia. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
PLong
by unfair_advantage
10
ECPG Technical Analysis 🧙Encore Capital Group Inc is a specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchase portfolios of defaulted consumer receivables at deep discounts to face value and manage them by working with individuals as they repay their obligations and work toward financial recovery. Encore has only a reportable segment being portfolio purchasing and recovery. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:ECPGLong
by unfair_advantage
ATNM Technical Analysis 🧙Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
AMEX:ATNMLong
by unfair_advantage
ZKIN about to hit my 300% target!As you may notice, I've posted several Stock post about this unknown NASDAQ company based in China, ZKIN. For a bit of fundamentals, checkout my first idea where the price was located at $2.00, 100% profit already! As the price of ZKIN continues to be in a strong uptrend, breaking into new recent highs, a price of $6.00 per share would be nothing unusual to see! That would lead to another 50% increase from current price and a 300% increase from my first ZKIN outlook. The weekly resistance levels are located at $4.70, $6.00 and $6.80. So a break of $4.70 can easily result in a whopping 27% increase in few days. But as the price of ZKIN likes to ride on 20 EMA, the price seems a bit overextended and a healthy correction to $3.30 area is also likely to be seen, where it may be a good idea to get into this stock! Buying dips is a good strategy in a strong uptrend, if you know where the dip will be located. MACD after a strong selling wave gave a buy signal and buying volume keeps increasing. RSI is above 60 which signifies that strong bullish momentum is present, a break below 60 will lead to a correction to $3.30 area. So either buy a break of recent high at $4.67 or buy a dip at $3.30 area. If you are looking for the best risk reward and greedy, look to buy dips at 50 EMA at $2.70 per share where the price can also be headed in a strong correction.
NASDAQ:ZKINLong
by TiborVrbovsky
3
$BNGO LONG - BEST PICK OF 2021We see very strong uptrend since December 29, stock successfully got listed on Nasdaq after maintaining position above regulations-stated price -> 1$. This stock is treasure in our hands trading for the very minimum price for now, the potential it got doesn't have borders and ranges. But according to trend lines, that make us set ranges, we can simply see +100% growth since the breakout happens in following weeks of February! And this is just the start, $BNGO can be the best investment anyone can get right now at this discounted price. Do your analysis and research before investing anywhere. Above stated ,isn't financial advice. >>>>> You can check recordings from BNGO's 5-day Next-Generation Cytogenomics Symposium, which took place from January 11 to 15 and featured 33 presentations by Saphyr users, are now available online on the company's website and its YouTube page. This event was by far its highest attended to date, with more than 15,500 session registrations and more than 6,400 session views from around the world. With the presentation recordings now available online, the impact of the event can continue to grow and expand awareness of Bionano Genomics and its Saphyr system for optical genome mapping and structural variation analysis. The event brought together scientists from leading hospitals and medical research institutions from the United States, Europe, China and Australia and covered applications of optical genome mapping (OGM) with Saphyr to study a variety of genetic diseases, blood cancers, solid tumors and repeat disorders as well as the studies supporting validation of clinical assays developed by Saphyr users. The last day of the symposium was dedicated to the study of the genomes of severely ill COVID-19 patients. Erik Holmlin, PhD, CEO of Bionano Genomics, commented: "The symposium was our most prominent showcase to date of how Saphyr comprehensively detects structural variations in a wide range of clinical and research applications. We are pleased by the enthusiasm we have seen from the scientific community around the world, and the impact of the symposium on our effort to sell Saphyr systems and access to its data through our services and reagent rental programs has been immediate. The availability of this scientific content on YouTube makes its discovery easy and continue to educate our customers on the power of Saphyr data." The recorded presentations of all speakers can be viewed their official website and on Bionano's YouTube page
NASDAQ:BNGOLong
by UnknownUnicorn10617434
4